Prosperodes GmbH
- Biotech or pharma, therapeutic R&D
- Other R&D services
At Prosperodes, we are creating a highly specific biomarker panel for neurodegenerative disorders such as Alzheimer's, Parkinson's, ALS, DLB or frontotemporal dementia. Our proprietary SeRAS Technology (Seed Replication, Analysis and Subtyping) specifically detects disease-associated protein deposits. It will provide an unprecedented depth of information on seed biomarkers such as TDP-43, alpha-synuclein, tau proteins or amyloid beta for early drug discovery as well as clinical trials using precision medicine approaches.
Prosperodes is currently seeking strategic alliances and partnering opportunities in the fields of TDP-43-related diseases, tauopathies and synucleinopathies.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}